Company Overview of Juventas Therapeutics, Inc.
Juventas Therapeutics, Inc. discovers and develops biopharmaceutical therapies for regenerative medicine. It offers Stromal Derived Factor-1, a therapy that improves cardiac function, as well as enables to protect and repair tissues following organ–damage in pre–clinical disease models. The company also develops biopharmaceuticals that activate the natural repair process that occurs after an injury. In addition, it provides therapies for wound healing and peripheral vascular diseases. Juventas Therapeutics, Inc. was formerly known as AcelleRX Therapeutics, Inc. and changed its name to Juventas Therapeutics, Inc. in April 2009. The company was founded in 2007 and is based in Cleveland, Ohio.
10265 Carnegie Avenue
Cleveland, OH 44106-2130
Founded in 2007
Key Executives for Juventas Therapeutics, Inc.
Juventas Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|KVK-TECH, Inc.||United States|
|Endo Finco Inc.||United States|
|Carnrick Laboratories Inc.||United States|
|Perrigo Company||United States|
|Pedinol Pharmacal, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Juventas Therapeutics, Inc., please visit www.juventasinc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.